A Blood Test to Look at Cells of the Immune System in Healthy Children
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to learn more about some of the immune cells in the blood (CD4 cells, for example) of healthy children in order to better understand the differences in the blood cells of children infected with HIV.
Because children's bodies are still developing, their cells are different from those of adults, and their bodies respond differently to infections such as HIV. In order to understand how immune cells grow and mature so that they can fight HIV, it is important to see how these cells behave in normal children.
| Condition |
|---|
|
HIV Infections HIV Seronegativity |
| Study Type: | Observational |
| Official Title: | Mononuclear Cell Phenotyping in Normal Children |
| Estimated Enrollment: | 630 |
Early in life, the cells involved in immune selection differentiate into CD4+ and CD8+ cells. Currently there is insufficient information on the cell maturation and activation of these peripheral blood mononuclear cell (PBMC) subsets in normal children. The critical need for this information has been brought about by the pediatric HIV/AIDS epidemic, which requires the measurement of peripheral blood CD4+ T cells and other cells types for interpretation of HIV disease progression. The immunopathogenesis of pediatric HIV infection differs from that in adults but is not well understood. In order to better understand HIV disease progression in HIV-infected children, these PBMC subsets must be studied in normal children so that control values can be established.
Healthy infants, children, and adolescents presenting for routine care or elective surgery have a single blood sample obtained. Blood is used for complete blood count, peripheral blood mononuclear cell flow analysis for surface markers, and plasma and cell storage. Demographic information including age, sex, race, and ethnicity is obtained at the time of the blood draw. The reason for the patient's visit is also documented. No study drugs are administered or supplied as part of this study. Statistical analysis is used to estimate the median distribution of each CD4 and CD8 subset.
Eligibility| Ages Eligible for Study: | up to 18 Years (Child, Adult) |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria
A child may be eligible for this study if he/she:
- Is 0 - 18 years old.
- Is HIV-negative and is born to an HIV-negative mother.
- Is healthy (no serious infection or disease).
- Has signed informed consent of a parent or legal guardian if under 18.
Exclusion Criteria
A child will not be eligible for this study if he/she:
- Is pregnant or breast-feeding.
- Has already completed this study once before.
- Is taking prescription medications other than prescription vitamins.
Contacts and LocationsPlease refer to this study by its ClinicalTrials.gov identifier: NCT00001109
Show 45 Study Locations
| Study Chair: | W Shearer | |
| Study Chair: | H Rosenblatt |
More Information
Publications:
| ClinicalTrials.gov Identifier: | NCT00001109 History of Changes |
| Other Study ID Numbers: | ACTG P1009 PACTG P1009 |
| Study First Received: | November 2, 1999 |
| Last Updated: | July 29, 2008 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institute of Allergy and Infectious Diseases (NIAID):
|
Monocytes Flow Cytometry HIV Seronegativity Phenotype Lymphocyte Subsets |
Additional relevant MeSH terms:
|
HIV Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases |
ClinicalTrials.gov processed this record on September 29, 2016